Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001965301-24-000163
Filing Date
2024-12-18
Accepted
2024-12-18 16:33:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2884
  Complete submission text file 0001965301-24-000163.txt   4347
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-40782 | Film No.: 241559720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UOVANT SCIENCES, INC. 5151 CALIFORNIA AVENUE, SUITE 250 IRVINE CA 92617
Business Address
Sukhatme Mayukh (Reporting) CIK: 0001750050 (see all company filings)

Type: 144